A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
Clinical trial NCT00000391 · COMPLETED
Trial details
- NCT number
- NCT00000391
- Sponsor
- National Institute of Mental Health (NIMH)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1988-01-01
- Primary completion
- 1990-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.